by John Conrad | Aug 20, 2024 | NewsBrief
According to PitchBook’s latest Emerging Tech Research report on the medtech industry, the sector is showing resilience and growth despite recent market challenges. The report highlights the successful IPO of precision medicine company Tempus in June 2024 as a...
by John Conrad | Jul 25, 2024 | iBIO News
We’re trying something new! Welcome to the first NewsBrief Innovation Insider Interview, where we chat with leaders from the biotech, pharma, medtech, venture capital and science community and explore cutting-edge ideas and strategies to help you gain actionable...
by John Conrad | Jun 21, 2024 | iBIO News
Illinois Biotechnology Innovation Organization Announces Rheoxtech as Winner of Inaugural Timothy P. Walbert Entrepreneurship Impact Award CHICAGO, IL (June 21, 2024) – The Illinois Biotechnology Innovation Organization (iBIO) is pleased to announce that Rheoxtech has...
by John Conrad | Jun 13, 2024 | iBIO News
With just a week to go, the excitement is building for the iBIO Timothy P. Walbert Entrepreneurship Impact Award Competition finals on June 20th at Fulton Market Aberdeen. Six trailblazing companies are set to showcase their groundbreaking innovations in biotech,...
by John Conrad | Jun 5, 2024 | NewsBrief
Abbott Laboratories has received clearance from the U.S. Food and Drug Administration (FDA) to sell its Lingo glucose monitor over the counter, without a prescription. The clearance, which came on May 29 according to the FDA’s website, positions Abbott to...
